Physician profile
Mir A Ali
NPI 1922034909
$973.86
in general payments reported to CMS, 2019-2025
11 companies · $38.87 in 2025
The $38.87 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2021: $664 · 2023: $14.94 · 2025: $38.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $664.45 | 2021 | |
| Merck Sharp & Dohme LLC | $108.17 | 2019 | |
| Cranial Technologies, INC | $45.07 | 2019 | |
| Glaxosmithkline, LLC. | $25.67 | 2019 | |
| Genzyme Corporation | $22.62 | 2025 | |
| Allergan, INC. | $22.28 | 2019 | |
| Amgen INC. | $21.43 | 2019 | |
| Novo Nordisk INC | $16.81 | 2019 | |
| Viatris Specialty LLC | $16.25 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.17 | 2019 | |
| Carlsmed, INC. | $14.94 | 2023 | Aprevo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mir Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.